{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:37:32Z","timestamp":1792179452301,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2103100"],"award-info":[{"award-number":["2021YFC2103100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20201344"],"award-info":[{"award-number":["BK20201344"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.actbio.2022.12.027","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T20:22:26Z","timestamp":1671567746000},"page":"734-746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Engineered bacteria combined with doxorubicin nanoparticles suppress angiogenesis and metastasis in murine melanoma models"],"prefix":"10.1016","volume":"158","author":[{"given":"Meiyang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8362-0237","authenticated-orcid":false,"given":"Mariana","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7546-7420","authenticated-orcid":false,"given":"Lipeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2022.12.027_bib0001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.copbio.2020.03.001","article-title":"Metabolic cell communication within tumour microenvironment: models, methods and perspectives","volume":"63","author":"Parri","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"issue":"5","key":"10.1016\/j.actbio.2022.12.027_bib0002","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2022.12.027_bib0003","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41401-020-0423-5","article-title":"Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells","volume":"41","author":"Qi","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.actbio.2022.12.027_bib0004","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41401-020-0426-2","article-title":"Nanomedicine and cancer immunotherapy","volume":"41","author":"Yu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.actbio.2022.12.027_bib0005","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/ja309812z","article-title":"Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency","volume":"135","author":"Lesniak","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2022.12.027_bib0006","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41401-020-0424-4","article-title":"Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment","volume":"41","author":"Sun","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.actbio.2022.12.027_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112274","article-title":"Hypoxia-activated nanomedicines for effective cancer therapy","volume":"195","author":"Zhou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.027_bib0008","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41467-020-14963-0","article-title":"Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2022.12.027_bib0009","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1039\/D2BM00579D","article-title":"An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy","volume":"10","author":"Liu","year":"2022","journal-title":"Biomater. Sci."},{"issue":"5","key":"10.1016\/j.actbio.2022.12.027_bib0010","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.actbio.2022.12.027_bib0011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2013.00154","article-title":"The tumor microenvironment and strategies to improve drug distribution","volume":"3","author":"Saggar","year":"2013","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.actbio.2022.12.027_bib0012","first-page":"373","article-title":"Hydrogel-based controlled drug delivery for cancer treatment: a review","volume":"17","author":"Sun","year":"2020","journal-title":"Mol. Pharm."},{"issue":"45","key":"10.1016\/j.actbio.2022.12.027_bib0013","doi-asserted-by":"crossref","first-page":"18136","DOI":"10.1021\/jacs.9b08669","article-title":"Enzyme-instructed activation of pro-protein therapeutics in vivo","volume":"141","author":"Chang","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.actbio.2022.12.027_bib0014","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nnano.2016.137","article-title":"Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions","volume":"11","author":"Felfoul","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.actbio.2022.12.027_bib0015","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.7150\/thno.16135","article-title":"RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated salmonella-mediated cancer therapy","volume":"6","author":"Park","year":"2016","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.actbio.2022.12.027_bib0016","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1128\/AEM.01390-12","article-title":"Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein","volume":"78","author":"Zhang","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"issue":"7","key":"10.1016\/j.actbio.2022.12.027_bib0017","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.027_bib0018","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/acsnano.1c08350","article-title":"Engineered bacteria for enhanced radiotherapy against breast carcinoma","volume":"16","author":"Pan","year":"2022","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.actbio.2022.12.027_bib0019","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1158\/2159-8290.CD-11-0201","article-title":"A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy","volume":"2","author":"Flentie","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.actbio.2022.12.027_bib0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3332\/ecancer.2017.751","article-title":"Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy","volume":"11","author":"Javan","year":"2017","journal-title":"Ecancermedicalscience"},{"issue":"7","key":"10.1016\/j.actbio.2022.12.027_bib0021","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1093\/nar\/gkr1041","article-title":"Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic","volume":"40","author":"Leschner","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.actbio.2022.12.027_bib0022","article-title":"Combination of bacterial-photothermal therapy with an anti-PD-1 peptide depot for enhanced immunity against advanced cancer","volume":"30","author":"Chen","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"52","key":"10.1016\/j.actbio.2022.12.027_bib0023","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1039\/C9CC02782C","article-title":"Dual detection of bioaccumulated Hg2+ based on luminescent bacteria and aggregation-induced emission\u2020","volume":"55","author":"Huang","year":"2019","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.actbio.2022.12.027_bib0024","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00262-021-03139-4","article-title":"Vaccination against galectin\u20111 promotes cytotoxic T\u2011cell infiltration in melanoma and reduces tumor burden","volume":"71","author":"Femel","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.actbio.2022.12.027_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100678","article-title":"Recent progress in and challenges in cellular therapy using NK cells for hematological malignancies","volume":"44","author":"Tanaka","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.actbio.2022.12.027_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212126","article-title":"Emerging approaches for solid tumor treatment using CAR-T cell therapy","volume":"22","author":"Chung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.actbio.2022.12.027_bib0027","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.nanolett.1c00209","article-title":"Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy","volume":"21","author":"Baicheng Wei","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2022.12.027_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105977","article-title":"Microbiota modulate doxorubicin induced cardiotoxicity","volume":"166","author":"An","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.027_bib0029","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1038\/s41598-020-67277-y","article-title":"Glycogen as an advantageous polymer carrier in cancer theranostics: straightforward in vivo evidence","volume":"10","author":"Galisova","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2022.12.027_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biomaterials.2018.05.024","article-title":"Glycogen-nucleic acid constructs for gene silencing in multicellular tumor spheroids","volume":"176","author":"Wojnilowicz","year":"2018","journal-title":"Biomaterials"},{"issue":"20","key":"10.1016\/j.actbio.2022.12.027_bib0031","doi-asserted-by":"crossref","first-page":"23311","DOI":"10.1021\/acsami.0c02785","article-title":"Phospholipid-decorated glycogen nanoparticles for stimuli-responsive drug release and synergetic chemophotothermal therapy of hepatocellular carcinoma","volume":"12","author":"Zhou","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.actbio.2022.12.027_bib0032","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tibs.2014.03.001","article-title":"Heparan sulfate signaling in cancer","volume":"39","author":"Knelson","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"12","key":"10.1016\/j.actbio.2022.12.027_bib0033","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1158\/0008-5472.CAN-05-3582","article-title":"HSulf-1 inhibits angiogenesis and tumorigenesis in vivo","volume":"66","author":"Narita","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2022.12.027_bib0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1465-9921-13-69","article-title":"HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells","volume":"13","author":"Zhang","year":"2012","journal-title":"Respir. Res."},{"issue":"10","key":"10.1016\/j.actbio.2022.12.027_bib0035","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1349-7006.2011.02024.x","article-title":"HSulf-1 inhibits cell proliferation and invasion in human gastric cancer","volume":"102","author":"Li","year":"2011","journal-title":"Cancer Sci."},{"issue":"50","key":"10.1016\/j.actbio.2022.12.027_bib0036","doi-asserted-by":"crossref","first-page":"35177","DOI":"10.1074\/jbc.M109.053801","article-title":"Heparin\/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity","volume":"284","author":"Myette","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.actbio.2022.12.027_bib0037","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2022.12.027_bib0038","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ijc.28070","article-title":"Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death","volume":"133","author":"Hodge","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.027_bib0039","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40425-018-0381-3","article-title":"White paper on microbial anti-cancer therapy and prevention","volume":"6","author":"Forbes","year":"2018","journal-title":"J. Immunother. Cancer"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122008297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122008297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:02:39Z","timestamp":1761674559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122008297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"alternative-id":["S1742706122008297"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.12.027","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered bacteria combined with doxorubicin nanoparticles suppress angiogenesis and metastasis in murine melanoma models","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}